Trials / Unknown
UnknownNCT05031702
Camelia Sinensis for Basal Metabolism and Body Composition
Effectiveness of the Assumption of a Supplement Based on the Extract From Camelia Leaf Sinensis on Basal Metabolism and Body Composition in Overweight Women or With Obesity in Postmenopause
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- Azienda di Servizi alla Persona di Pavia · Academic / Other
- Sex
- Female
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Camellia Sinensis leaf extract contributes to increasing energy expenditure and calorie consumption by increasing thermogenesis. The purpose of this study is to evaluate the efficacy of Camellia Sinensis on basal metabolism and body composition in overweight women or with obesity in postmenopause.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Camellia Sinensis leaf extract | 2 tablets per day of 150 mg (1 before lunch and 1 before dinner) |
| COMBINATION_PRODUCT | Placebo | 2 tablets per day of 150 mg (1 before lunch and 1 before dinner) |
Timeline
- Start date
- 2021-03-08
- Primary completion
- 2022-01-03
- Completion
- 2022-07-25
- First posted
- 2021-09-02
- Last updated
- 2022-03-03
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05031702. Inclusion in this directory is not an endorsement.